Immunology is an essential part of any multidisciplinary approach to the study of human cancer. As such, the Training Program in Cancer Immunology will utilize as its foundation the existing strength in this area in the Department of Microbiology and Immunology, which is the core of the Kimmel Cancer Center (KCC). Students in the Training Program will be enrolled in the KCC's Immunology Graduate Program and will obtain a Ph.D. degree in Immunology. The goal of the Program is to provide aspiring researchers with the training and experience necessary for them to develop careers as independent scientific investigators. Research training is based on thesis work under the guidance of a preceptor and a Thesis Research Committee. In addition, trainees actively participate in Program functions such as seminars, journal clubs, and research discussion groups, all designed to enrich their educational experience. ? ? Predoctoral students are required to take a core curriculum in Immunology which consists initially of courses in the Fundamentals of Immunology, Biochemistry, Molecular Biology, Cell Biology, Genetics, and Microbiology. This foundation curriculum is then followed by five advanced courses in Immunology, over a two-year period, covering a variety of topics in Tumor Immunology, Molecular Immunology and Immunogenetics, Cellular Immunology, Immunopathology, and Infection and Immunity. Trainees are also required to take Pathobiology of Cancer, the Molecular Basis of Cancer and to attend the KCC Translational Opportunities in Cancer Research Meetings. Students are required to complete three rotations in the laboratories of research preceptors with diverse interests in Immunology, before choosing a preceptor and direction for thesis work. Students periodically present seminars throughout their training and are required to present their research progress to their Thesis Research Committee twice a year. With the consultation of the Thesis Research Committee and the supervisory Graduate Studies Committee, the student may adapt the curriculum to fit his/her interests or prior experience. Students are constantly monitored and evaluated throughout their training and must pass a comprehensive exam at the end of their course work in the form of an oral defense of a written grant proposal. ? ? The program of study leading to a Ph.D. degree is open to students who hold a Bachelor's degree from an accredited institution who wish to enter biomedical research, as well as individuals who already hold or will obtain other professional degrees (M.D., D.O., D.V.M., or D.D.S.) and who wish to pursue an independent academic research career. Acceptance into the Program is based on the criteria of grade point average, GRE scores, research experience, letters of recommendation, and an interview. ? ? For the postdoctoral program, applicants must hold a Ph.D. or equivalent doctoral degree, and acceptance will depend upon past research and educational experience. The goal of this program is to develop highly trained, technically competent research scientists capable of performing and ultimately directing research in Immunology. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009683-13
Application #
6932381
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1993-02-05
Project End
2008-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
13
Fiscal Year
2005
Total Cost
$185,974
Indirect Cost
Name
Thomas Jefferson University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Waldron, T; De Dominici, M; Soliera, A R et al. (2012) c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia 26:644-53
Crist, Richard C; Roth, Jacquelyn J; Waldman, Scott A et al. (2011) A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. PLoS One 6:e23665
Landrette, S F; Madera, D; He, F et al. (2011) The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells. Leukemia 25:655-62
Neely, R J; Brose, M S; Gray, C M et al. (2011) The RET/PTC3 oncogene activates classical NF-?B by stabilizing NIK. Oncogene 30:87-96
Crist, Richard C; Roth, Jacquelyn J; Lisanti, Michael P et al. (2011) Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis. Cell Cycle 10:1092-9
Crist, Richard C; Roth, Jacquelyn J; Baran, Amy A et al. (2010) The armadillo repeat domain of Apc suppresses intestinal tumorigenesis. Mamm Genome 21:450-7
Shriner, Anne K; Liu, Hongqi; Sun, Guizhi et al. (2010) IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae. J Immunol 185:525-31
Pufnock, Jeff S; Rothstein, Jay L (2009) Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression. J Immunol 182:5498-506
Lidonnici, Maria Rosa; Corradini, Francesca; Waldron, Todd et al. (2008) Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood 111:4771-9
Coffey, Francis; Liu, Xiaohe; Manser, Tim (2007) Primary development and participation in a foreign antigen-driven immune response of a chromatin-reactive B cell clonotype are not influenced by TLR9 or other MyD88-dependent TLRs. J Immunol 179:6663-72

Showing the most recent 10 out of 44 publications